There are no definitive dosing guidelines from regulatory bodies for DSIP in sleep disorders or for promoting deep sleep in healthy populations
Read "Best Time to Take GHK-Cu
In the 72-week non-diabetic obesity trial, adults lost -15.0% at 5 mg, -19.5% at 10 mg, and -20.9% at 15 mg. Real-world outcomes vary because dose reached, adherence, and baseline state vary
The medication is administered via subcutaneous injection, typically on a weekly basis, though dosing frequency and amounts may be individualized based on patient response and tolerability
Drug design, development and therapy , 16 , 19631974.
It aids in the production of red blood cells, supports nerve function, and helps in the creation of DNA